The Most Deadly Types of Cancer in the United States

Why Death Rates Matter More Than Incidence Rates

A lot of people confuse 'most common cancer' with 'most deadly cancer.' They're not the same thing. Basal cell skin cancer is extraordinarily common, but it kills very few people. Pancreatic cancer is far less common—but its death rate is brutal. So when we talk about deadly cancers, we're really talking about the ratio of diagnoses to deaths, plus the raw number of lives lost each year.

The American Cancer Society publishes mortality data annually, and the same five or six cancers keep appearing at the top. That consistency tells you something. These aren't statistical flukes. They reflect real biological challenges—tumors that grow silently, spread fast, or simply don't respond well to what we currently have in the treatment toolbox.

Your age, sex, family history, and habits all shift your personal risk within these numbers. The national statistics are a starting point, not a verdict.

Lung Cancer: Still the Biggest Killer

Lung cancer kills more Americans than colorectal, breast, and prostate cancers combined. Around 125,000 deaths a year. Let that sink in for a second. It's not that lung cancer is the most commonly diagnosed cancer—it's that most cases are caught late, at stage III or IV, when surgery isn't on the table and the disease has already spread.

Smoking is the obvious culprit, responsible for roughly 80–85% of cases. But radon gas in homes is the second-leading cause, and most people have never tested their basement. If you've smoked at least a pack a day for 20 years and you're between 50 and 80, you're eligible for low-dose CT screening covered by most insurance plans. That scan can genuinely catch things early enough to matter.

Non-small cell lung cancer and small cell lung cancer behave very differently. Treatment options have expanded a lot in the last decade—immunotherapy and targeted therapy have changed survival curves for certain patients—but early detection is still your best lever.

• Quit smoking: risk drops significantly within 10 years
• Test your home for radon—kits cost under $15 at hardware stores
• Ask your doctor if low-dose CT screening applies to you
• Secondhand smoke exposure counts toward your risk history

Colorectal Cancer: Very Preventable, Still Very Deadly

Here's the frustrating thing about colorectal cancer: colonoscopy can literally prevent it, not just detect it, by removing precancerous polyps before they turn malignant. And yet it's still the second-leading cause of cancer death in the US, killing around 52,000 people annually. Why? Because a lot of people skip the screening. It's uncomfortable to think about, the prep is unpleasant, and symptoms often don't show up until the cancer is advanced.

Screening now starts at age 45 for average-risk adults—that recommendation dropped from 50 a few years ago because rates in younger people are rising, especially in adults in their 30s and 40s. Nobody fully understands why yet. Diet, gut microbiome changes, obesity, and sedentary lifestyles are all suspected contributors.

If a colonoscopy every 10 years feels like too much, there are alternatives—Cologuard stool DNA tests every 3 years, or fecal immunochemical tests annually. Talk to your doctor about which option fits your situation. The worst choice is no screening at all.

Breast Cancer and the Role of Hormone-Blocking Therapy

Breast cancer is the most commonly diagnosed cancer in American women, and it kills around 42,000 women per year. Survival rates have improved dramatically over the decades—mammography, better surgical techniques, and targeted drugs all deserve credit. But it's still a top-five killer, and certain subtypes are particularly aggressive.

One of the most established treatments for hormone receptor-positive breast cancer—the most common type—is tamoxifen. It's been used for over 40 years. Tamoxifen works by blocking estrogen receptors in breast tissue, essentially cutting off a fuel source that some tumors depend on. Oncologists prescribe it for early-stage breast cancer after surgery, for advanced disease, and sometimes as preventive therapy in high-risk women who haven't been diagnosed yet.

If your oncologist has recommended tamoxifen, you might be taking it for 5 to 10 years. Cost is a real concern for a lot of patients on long-term therapy. Generic tamoxifen is available and is bioequivalent to the brand-name version. We carry it at Chep Meds USA, and the price difference compared to retail pharmacy can be meaningful over a multi-year course. Always keep your prescribing oncologist in the loop about any changes to your medication source.

• Tamoxifen is taken daily, usually 20 mg, for 5–10 years post-diagnosis
• Common side effects include hot flashes, joint pain, and mood changes
• It slightly increases the risk of blood clots and uterine cancer—your doctor monitors for this
• Annual mammograms remain important even while on tamoxifen

Pancreatic Cancer: The One That Moves Too Fast

Pancreatic cancer has a five-year survival rate of about 12%. That number is grim, and it hasn't moved much despite decades of research. The pancreas sits deep in the abdomen, hidden behind other organs. By the time someone notices something's wrong—maybe jaundice, unexplained weight loss, or new-onset diabetes after age 50—the cancer has usually already spread.

There's no reliable routine screening test for the general population. Researchers are working on blood biomarker tests, but nothing is ready for widespread clinical use yet. People with certain genetic mutations (BRCA2, PALB2, Lynch syndrome) and those with a strong family history may qualify for surveillance at specialized centers.

Smoking, obesity, heavy alcohol use, chronic pancreatitis, and type 2 diabetes are all associated with higher pancreatic cancer risk. Controlling what you can control matters here more than it might seem, because prevention is essentially the only tool the average person has right now.

Prostate and Liver Cancer: Two Very Different Threats

Prostate cancer kills around 34,000 American men a year. The paradox of prostate cancer is that a huge number of men die with it rather than from it—slow-growing prostate tumors in older men often never become life-threatening. But aggressive prostate cancer absolutely does. The PSA test and digital rectal exam remain debated screening tools because they can lead to overtreatment of non-dangerous tumors. Talk with your doctor about whether and when to screen based on your age and family history.

Liver cancer is different in character. It's less common in raw numbers but is rising faster than almost any other cancer in the US. Most cases are linked to chronic hepatitis B or C infection, heavy alcohol use, or non-alcoholic fatty liver disease—which is increasingly common as obesity rates climb. The Hepatitis C treatments available today can cure the infection in over 95% of patients, which directly reduces liver cancer risk. If you were born between 1945 and 1965, you should be tested for hepatitis C once; many people in that generation were exposed without knowing it.

What You Can Actually Do With This Information

Reading a list of deadly cancers can feel overwhelming. So let's make it concrete. You probably have two or three actionable things you could do this week. Get your home radon tested. Schedule a colonoscopy you've been putting off. Ask your doctor whether you qualify for lung cancer CT screening. If you're a woman in your 40s, talk about mammogram timing. None of these are exotic. They're just often delayed.

Family history shapes your personal risk in ways that generic statistics can't capture. If a first-degree relative had pancreatic cancer, ovarian cancer, or early-onset colorectal cancer, mention it explicitly to your primary care doctor. It may change what screening you're offered and when.

For people already in treatment—whether that's chemotherapy, immunotherapy, hormone-blocking drugs like tamoxifen, or something else—medication adherence is one of the most important factors in outcomes. Long-term medications are only effective if you keep taking them, and cost shouldn't be the reason you stop. If affordability is a barrier, ask your pharmacist about generics, patient assistance programs, or lower-cost dispensing options. That conversation is always worth having.

• Schedule overdue screenings—colonoscopy, mammogram, low-dose CT if eligible
• Tell your doctor your full family cancer history, not just your own
• Don't stop prescribed cancer medications because of cost without exploring options first
• Lifestyle factors—weight, smoking, alcohol—touch nearly every cancer on this list

Common questions